(Q33503713)

27 July 2017

title

Identification of potential serum markers for endometrial cancer using protein expression profiling (English)

1 reference

27 July 2017

1 reference

8

Noriaki Sakuragi

1 reference

27 July 2017

11

Nobuo Yaegashi

1 reference

27 July 2017

10

Toru Sugiyama

1 reference

27 July 2017

7

Junzo Kigawa

1 reference

27 July 2017

1

Masashi Takano

1 reference

27 July 2017

Yoshihiro Kikuchi

2

1 reference

27 July 2017

Takayoshi Asakawa

3

1 reference

27 July 2017

Tomoko Goto

4

1 reference

27 July 2017

Tsunekazu Kita

5

1 reference

27 July 2017

Kazuya Kudoh

6

1 reference

27 July 2017

Masaru Sakamoto

9

1 reference

27 July 2017

Hiroshi Tsuda

12

1 reference

27 July 2017

Hiroshi Seto

13

1 reference

27 July 2017

Mieko Shiwa

14

1 reference

27 July 2017

publication date

16 September 2009

1 reference

Journal of Cancer Research and Clinical Oncology

27 July 2017

published in

1 reference

27 July 2017

volume

136

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

475-481

1 reference

Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.

27 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-009-0680-7

Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.

21 January 2018

1 reference

12 December 2020

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

1 reference

12 December 2020

PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations

1 reference

12 December 2020

Altered protein expression in endometrial carcinogenesis

1 reference

12 December 2020

Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding

1 reference

12 December 2020

Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers

1 reference

12 December 2020

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression

1 reference

12 December 2020

K-ras mutations in endometrial carcinomas with microsatellite instability

1 reference

12 December 2020

Inflammation and cancer

1 reference

12 December 2020

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

1 reference

12 December 2020

The CA 125 tumour-associated antigen: a review of the literature

1 reference

12 December 2020

The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma

1 reference

12 December 2020

High-density lipoprotein: antioxidant and anti-inflammatory properties

1 reference

12 December 2020

Clinical usefulness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma.

1 reference

12 December 2020

Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells

1 reference

12 December 2020

Characterization of serum biomarkers for detection of early stage ovarian cancer

1 reference

12 December 2020

Concomitant activation of AKT with extracellular-regulated kinase 1/2 occurs independently of PTEN or PIK3CA mutations in endometrial cancer and may be associated with favorable prognosiss.

1 reference

12 December 2020

Intratumoral heterogeneous expression of p53 correlates with p53 mutation, Ki-67, and cyclin A expression in endometrioid-type endometrial adenocarcinomas

1 reference

12 December 2020

Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis

1 reference

12 December 2020

Molecular identification of latent precancers in histologically normal endometrium.

1 reference

12 December 2020

The association between lipid profiles and breast cancer among Taiwanese women.

1 reference

12 December 2020

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

1 reference

12 December 2020

Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer

1 reference

12 December 2020

Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10

1 reference

12 December 2020

Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling

1 reference

12 December 2020

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

1 reference

12 December 2020

Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis

1 reference

12 December 2020

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

12 December 2020

Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays

1 reference

12 December 2020

Serum lipids concentration in women with benign and malignant ovarian tumours.

1 reference

12 December 2020

Serum tumor markers in the management of ovarian, endometrial and cervical cancer

1 reference

12 December 2020

Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.

1 reference

12 December 2020

10.1007/S00432-009-0680-7

Identifiers

DOI

1 reference

27 July 2017

1 reference